These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 33152323)

  • 21. Catabolic pathways regulated by mTORC1 are pivotal for survival and growth of cancer cells expressing mutant Ras.
    Sung S; Choi J; Cheong H
    Oncotarget; 2015 Dec; 6(38):40405-17. PubMed ID: 26575954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promising Therapeutic Approach in Pancreatic Cancer: Metabolism-Related Genes.
    Choe S; Kwak W; Kim E; Shin S; Shin M; Koh HJ; Yoon H
    Front Biosci (Landmark Ed); 2024 Apr; 29(4):137. PubMed ID: 38682209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC1 regulates PDGFA expression during pancreatic cancer progression.
    Sahraei M; Roy LD; Curry JM; Teresa TL; Nath S; Besmer D; Kidiyoor A; Dalia R; Gendler SJ; Mukherjee P
    Oncogene; 2012 Nov; 31(47):4935-45. PubMed ID: 22266848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting miR-21 for the therapy of pancreatic cancer.
    Sicard F; Gayral M; Lulka H; Buscail L; Cordelier P
    Mol Ther; 2013 May; 21(5):986-94. PubMed ID: 23481326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UBL4A inhibits autophagy-mediated proliferation and metastasis of pancreatic ductal adenocarcinoma via targeting LAMP1.
    Chen H; Li L; Hu J; Zhao Z; Ji L; Cheng C; Zhang G; Zhang T; Li Y; Chen H; Pan S; Sun B
    J Exp Clin Cancer Res; 2019 Jul; 38(1):297. PubMed ID: 31288830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrin alpha-V is an important driver in pancreatic adenocarcinoma progression.
    Kemper M; Schiecke A; Maar H; Nikulin S; Poloznikov A; Galatenko V; Tachezy M; Gebauer F; Lange T; Riecken K; Tonevitsky A; Aigner A; Izbicki J; Schumacher U; Wicklein D
    J Exp Clin Cancer Res; 2021 Jun; 40(1):214. PubMed ID: 34174926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carcinogenesis of Pancreatic Ductal Adenocarcinoma.
    Storz P; Crawford HC
    Gastroenterology; 2020 Jun; 158(8):2072-2081. PubMed ID: 32199881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
    Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
    Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer.
    Von Marschall Z; Scholz A; Stacker SA; Achen MG; Jackson DG; Alves F; Schirner M; Haberey M; Thierauch KH; Wiedenmann B; Rosewicz S
    Int J Oncol; 2005 Sep; 27(3):669-79. PubMed ID: 16077915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular heterogeneity during mouse pancreatic ductal adenocarcinoma progression at single-cell resolution.
    Hosein AN; Huang H; Wang Z; Parmar K; Du W; Huang J; Maitra A; Olson E; Verma U; Brekken RA
    JCI Insight; 2019 Jul; 5(16):. PubMed ID: 31335328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges.
    Maertin S; Elperin JM; Lotshaw E; Sendler M; Speakman SD; Takakura K; Reicher BM; Mareninova OA; Grippo PJ; Mayerle J; Lerch MM; Gukovskaya AS
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G524-G536. PubMed ID: 28705806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas.
    Hidalgo M; Von Hoff DD
    Clin Cancer Res; 2012 Aug; 18(16):4249-56. PubMed ID: 22896691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.
    Fu Y; Liu S; Zeng S; Shen H
    Mol Cancer; 2018 Feb; 17(1):62. PubMed ID: 29458370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer.
    Schoeps B; Eckfeld C; Prokopchuk O; Böttcher J; Häußler D; Steiger K; Demir IE; Knolle P; Soehnlein O; Jenne DE; Hermann CD; Krüger A
    Cancer Res; 2021 Jul; 81(13):3568-3579. PubMed ID: 33941611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolism addiction in pancreatic cancer.
    Blum R; Kloog Y
    Cell Death Dis; 2014 Feb; 5(2):e1065. PubMed ID: 24556680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.
    Leca J; Martinez S; Lac S; Nigri J; Secq V; Rubis M; Bressy C; Sergé A; Lavaut MN; Dusetti N; Loncle C; Roques J; Pietrasz D; Bousquet C; Garcia S; Granjeaud S; Ouaissi M; Bachet JB; Brun C; Iovanna JL; Zimmermann P; Vasseur S; Tomasini R
    J Clin Invest; 2016 Nov; 126(11):4140-4156. PubMed ID: 27701147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cells.
    Chen YW; Hsiao PJ; Weng CC; Kuo KK; Kuo TL; Wu DC; Hung WC; Cheng KH
    BMC Cancer; 2014 Mar; 14():181. PubMed ID: 24625091
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heparin-binding epidermal growth factor-like growth factor eliminates constraints on activated Kras to promote rapid onset of pancreatic neoplasia.
    Ray KC; Moss ME; Franklin JL; Weaver CJ; Higginbotham J; Song Y; Revetta FL; Blaine SA; Bridges LR; Guess KE; Coffey RJ; Crawford HC; Washington MK; Means AL
    Oncogene; 2014 Feb; 33(7):823-31. PubMed ID: 23376846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.